Writer Joshua Patton recently complained about Trek’s “toxic fans” — aka conservatives, typically — a relatively new concept ...
Updated Phase 1 data for ELVN-001 expected mid-2025 as positive enrollment momentum continues Expected monotherapy and combination data from the ELVN-002 Phase 1 trials ...
Shuttle Pharma intends to use the net proceeds from the Offering to fund Shuttle Pharma’s Phase II clinical trial for its lead product candidate, for marketing and advertising services, and for ...
Lincoln Minerals is re-assaying historic core aiming to uncover new base metal potential in South Australia after it was only ...
MaxCyte will host a conference call today, March 11, 2025, at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call are required to register online. A live and archived ...
Media agencies have not yet had contact from Warner Bros. Discovery (WBD) about the advertising options on its new streaming ...
Spring has spring and it’s a great time to check out the arts scene in the Lehigh Valley. Here’s a preview of some of this ...
Dr. Anatoly Dritschilo remains Chairman of the Board and Co-CEO overseeing scientific and clinical trial activities.
We look forward to continued positive exploration results at Detour East during 2025,” concluded Mr. Penny. The 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results